80_FR_29110 80 FR 29013 - Center for Scientific Review; Notice of Closed Meetings

80 FR 29013 - Center for Scientific Review; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 80, Issue 97 (May 20, 2015)

Page Range29013-29014
FR Document2015-12242

Federal Register, Volume 80 Issue 97 (Wednesday, May 20, 2015) 
[Federal Register Volume 80, Number 97 (Wednesday, May 20, 2015)]
[Notices]
[Pages 29013-29014]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-12242]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Oncology 2--Translational Clinical Integrated 
Review

[[Page 29014]]

Group; Radiation Therapeutics and Biology Study Section.
    Date: June 15-16, 2015.
    Time: 8:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military 
Road NW., Washington, DC 20015.
    Contact Person: Bo Hong, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 6194, MSC 7804, Bethesda, MD 20892, 301-996-
6208, hongb@csr.nih.gov.

    Name of Committee: Biobehavioral and Behavioral Processes 
Integrated Review Group; Motor Function, Speech and Rehabilitation 
Study Section.
    Date: June 15, 2015.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: St. Gregory Hotel, 2033 M Street NW., Washington, DC 
20036.
    Contact Person: Biao Tian, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 3166, MSC 7848, Bethesda, MD 20892, 301-402-
4411, tianbi@csr.nih.gov.

    Name of Committee:Oncology 2--Translational Clinical Integrated 
Review Group; Cancer Biomarkers Study Section.
    Date: June 17, 2015.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military 
Road NW., Washington, DC 20015.
    Contact Person: Lawrence Ka-Yun Ng, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 6152, MSC 7804, Bethesda, MD 
20892, 301-357-9318, ngkl@csr.nih.gov.

    Name of Committee: Endocrinology, Metabolism, Nutrition and 
Reproductive Sciences Integrated Review Group; Cellular Aspects of 
Diabetes and Obesity Study Section.
    Date: June 18, 2015.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Doubletree Hotel Bethesda (Formerly Holiday Inn Select), 
8120 Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Alexander D Politis, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3210, MSC 7808, Bethesda, MD 
20892, (301) 435-1150, politisa@csr.nih.gov.

    Name of Committee: Endocrinology, Metabolism, Nutrition and 
Reproductive Sciences Integrated Review Group; Molecular and 
Cellular Endocrinology Study Section.
    Date: June 18, 2015.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, 
MD 20814.
    Contact Person: John Bleasdale, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 6170, MSC 7892, Bethesda, MD 
20892, 301-435-4514, bleasdaleje@csr.nih.gov.

    Name of Committee: Molecular, Cellular and Developmental 
Neuroscience Integrated Review Group; Synapses, Cytoskeleton and 
Trafficking Study Section.
    Date: June 18-19, 2015.
    Time: 8:30 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hotel Monaco Alexandria, 480 King Street, Alexandria, VA 
22314.
    Contact Person: Christine A Piggee, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4186, MSC 7850, Bethesda, MD 
20892, 301-435-0657, christine.piggee@nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, Traumatic Brain Injury and Cerebrovascular Disorders.
    Date: June 19, 2015.
    Time: 1:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Alexander Yakovlev, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5206, MSC 7846, Bethesda, MD 
20892-7846, 301-435-1254, yakovleva@csr.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: May 15, 2015.
Anna Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-12242 Filed 5-19-15; 8:45 am]
BILLING CODE 4140-01-P

Federal Register / Vol. 80, No. 97 / Wednesday, May 20, 2015 / Notices 29013 OMB, Attn: FDA Desk Officer, FAX: has submitted the following proposed notification under § 100.2(d) enables us 202–395–7285, or emailed to oira_ collection of information to OMB for to identify the food against which a submission@omb.eop.gov. All review and clearance. State intends to take action and to comments should be identified with the advise that State whether Federal State Enforcement Notifications—21 OMB control number 0910–0275. Also enforcement action against the food has CFR 100.2(d) include the FDA docket number found been taken or is in process. With certain in brackets in the heading of this OMB Control Number 0910–0275— narrow exceptions, Federal enforcement document. Extension action precludes State action under the Section 310(b) of the Federal Food, FD&C Act. FOR FURTHER INFORMATION CONTACT: FDA Drug, and Cosmetic Act (the FD&C Act) In the Federal Register of March 13, PRA Staff, Office of Operations, Food (21 U.S.C. 337(b)) authorizes a State to 2015 (80 FR 13392), FDA published a and Drug Administration, 8455 enforce certain sections of the FD&C Act 60-day notice requesting public Colesville Rd.; COLE–14526, Silver in their own name and within their own comment on the proposed collection of Spring, MD 20993–0002 PRAStaff@ jurisdiction. However, before doing so, information. No comments were fda.hhs.gov. a State must provide notice to FDA received. SUPPLEMENTARY INFORMATION: In according to 21 CFR 100.2. The We estimate the burden of this compliance with 44 U.S.C. 3507, FDA information required in a letter of collection of information as follows: TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1 Number of Average Number of Total annual 21 CFR section responses per burden per Total hours respondents responses respondents response 100.2(d) ................................................................................ 1 1 1 10 10 1 There are no capital costs or operating and maintenance costs associated with this collection of information. The estimated reporting burden for provisions set forth in sections (Catalogue of Federal Domestic Assistance § 100.2(d) is minimal because 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Program Nos. 93.853, Clinical Research enforcement notifications are seldom as amended. The grant applications and Related to Neurological Disorders; 93.854, used by States. During the last 3 years, the discussions could disclose Biological Basis Research in the Neurosciences, National Institutes of Health, we have not received any new confidential trade secrets or commercial HHS) enforcement notifications; therefore, we property such as patentable material, estimate that one or fewer notifications and personal information concerning Dated: May 14, 2015. will be submitted annually. Although individuals associated with the grant Carolyn Baum, we have not received any new applications, the disclosure of which Program Analyst, Office of Federal Advisory enforcement notifications in the last 3 would constitute a clearly unwarranted Committee Policy. years, we believe these information invasion of personal privacy. [FR Doc. 2015–12125 Filed 5–19–15; 8:45 am] collection provisions should be Name of Committee: National Institute of BILLING CODE 4140–01–P extended to provide for the potential Neurological Disorders and Stroke, Initial future need of a State government to Review Group, Neurological Sciences and submit enforcement notifications Disorders B. DEPARTMENT OF HEALTH AND informing us when it intends to take Date: June 25–26, 2015. HUMAN SERVICES enforcement action under the FD&C Act Time: 8:00 a.m. to 6:00 p.m. against a particular food located in the Agenda: To review and evaluate grant National Institutes of Health applications. State. Place: Wyndam Grand Chicago Riverfront Center for Scientific Review; Notice of Dated: May 15, 2015. Hotel, 71 E. Wacker Drive, Chicago, IL 60601. Closed Meetings Leslie Kux, Contact Person: Birgit Neuhuber, Ph.D., Scientific Review Officer, Scientific Review Pursuant to section 10(d) of the Associate Commissioner for Policy. Branch, Division of Extramural Research, [FR Doc. 2015–12236 Filed 5–19–15; 8:45 am] NINDS/NIH/DHHS/Neuroscience Center, Federal Advisory Committee Act, as BILLING CODE 4164–01–P 6001 Executive Boulevard, Suite 3208, MSC amended (5 U.S.C. App.), notice is 9529, Bethesda, MD 20892–9529, 301–496– hereby given of the following meetings. 3562, neuhuber@ninds.nih.gov. The meetings will be closed to the DEPARTMENT OF HEALTH AND Name of Committee: Neurological Sciences public in accordance with the HUMAN SERVICES Training Initial Review Group, NST–2 provisions set forth in sections Subcommittee. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., National Institutes of Health Date: June 29–30, 2015. Time: 8:00 a.m. to 4:00 p.m. as amended. The grant applications and National Institute of Neurological Agenda: To review and evaluate grant the discussions could disclose Disorders and Stroke; Notice of Closed applications. confidential trade secrets or commercial Place: The Fairmont Washington, DC, 2401 property such as patentable material, mstockstill on DSK4VPTVN1PROD with NOTICES Meetings M Street NW., Washington, DC 20037. and personal information concerning Pursuant to section 10(d) of the Contact Person: Elizabeth A. Webber, individuals associated with the grant Federal Advisory Committee Act, as Ph.D., Scientific Review Officer, Scientific applications, the disclosure of which Review Branch, Division of Extramural would constitute a clearly unwarranted amended (5 U.S.C. App.), notice is Research, NINDS/NIH/DHHS/Neuroscience hereby given of the following meetings. Center, 6001 Executive Boulevard, Suite invasion of personal privacy. The meetings will be closed to the 3208, MSC 9529, Bethesda, MD 20892–9529, Name of Committee: Oncology 2— public in accordance with the 301–496–1917, webbere@mail.nih.gov. Translational Clinical Integrated Review VerDate Sep<11>2014 23:50 May 19, 2015 Jkt 235001 PO 00000 Frm 00085 Fmt 4703 Sfmt 4703 E:\FR\FM\20MYN1.SGM 20MYN1

29014 Federal Register / Vol. 80, No. 97 / Wednesday, May 20, 2015 / Notices Group; Radiation Therapeutics and Biology Scientific Review, National Institutes of for companies and may also be available Study Section. Health, 6701 Rockledge Drive, Room 6170, for licensing. Date: June 15–16, 2015. MSC 7892, Bethesda, MD 20892, 301–435– FOR FURTHER INFORMATION CONTACT: Time: 8:00 a.m. to 4:00 p.m. 4514, bleasdaleje@csr.nih.gov. Agenda: To review and evaluate grant Licensing information and copies of the Name of Committee: Molecular, Cellular applications. U.S. patent applications listed below and Developmental Neuroscience Integrated Place: Embassy Suites at the Chevy Chase Review Group; Synapses, Cytoskeleton and may be obtained by writing to the Pavilion, 4300 Military Road NW., Trafficking Study Section. indicated licensing contact at the Office Washington, DC 20015. Date: June 18–19, 2015. of Technology Transfer, National Contact Person: Bo Hong, Ph.D., Scientific Time: 8:30 a.m. to 4:00 p.m. Institutes of Health, 6011 Executive Review Officer, Center for Scientific Review, Agenda: To review and evaluate grant Boulevard, Suite 325, Rockville, National Institutes of Health, 6701 Rockledge applications. Maryland 20852–3804; telephone: 301– Drive, Room 6194, MSC 7804, Bethesda, MD Place: Hotel Monaco Alexandria, 480 King 20892, 301–996–6208, hongb@csr.nih.gov. 496–7057; fax: 301–402–0220. A signed Street, Alexandria, VA 22314. Confidential Disclosure Agreement will Name of Committee: Biobehavioral and Contact Person: Christine A Piggee, Ph.D., Behavioral Processes Integrated Review be required to receive copies of the Scientific Review Officer, Center for Group; Motor Function, Speech and Scientific Review, National Institutes of patent applications. Rehabilitation Study Section. Health, 6701 Rockledge Drive, Room 4186, SUPPLEMENTARY INFORMATION: Date: June 15, 2015. MSC 7850, Bethesda, MD 20892, 301–435– Technology descriptions follow. Time: 8:00 a.m. to 6:00 p.m. 0657, christine.piggee@nih.gov. Agenda: To review and evaluate grant A Novel Therapeutic Vector for Name of Committee: Center for Scientific applications. Review Special Emphasis Panel, Traumatic Hemoglobin Disorders Place: St. Gregory Hotel, 2033 M Street Brain Injury and Cerebrovascular Disorders. Description of Technology: NW., Washington, DC 20036. Date: June 19, 2015. Investigators at the National Heart, Contact Person: Biao Tian, Ph.D., Scientific Time: 1:00 p.m. to 3:00 p.m. Review Officer, Center for Scientific Review, Lung, and Blood Institute have designed Agenda: To review and evaluate grant a novel lentiviral vector as a potential National Institutes of Health, 6701 Rockledge applications. Drive, Room 3166, MSC 7848, Bethesda, MD gene therapy for sickle cell anemia and Place: National Institutes of Health, 6701 20892, 301–402–4411, tianbi@csr.nih.gov. Rockledge Drive, Bethesda, MD 20892 beta-thalassemia. The novel lentiviral Name of Committee:Oncology 2— (Telephone Conference Call). vector encodes the beta-globin gene in a Translational Clinical Integrated Review Contact Person: Alexander Yakovlev, forward orientation and can produce 5– Group; Cancer Biomarkers Study Section. Ph.D., Scientific Review Officer, Center for 10 fold higher viral titer and 4–10 fold Date: June 17, 2015. Scientific Review, National Institutes of higher gene transfer efficiency to Time: 8:00 a.m. to 6:00 p.m. Health, 6701 Rockledge Drive, Room 5206, hematopoietic stem cells than reverse- Agenda: To review and evaluate grant MSC 7846, Bethesda, MD 20892–7846, 301– oriented lentiviral vectors. In vivo applications. 435–1254, yakovleva@csr.nih.gov. studies conducted in rhesus macaques Place: Embassy Suites at the Chevy Chase (Catalogue of Federal Domestic Assistance Pavilion, 4300 Military Road NW., show beta-globin production after Program Nos. 93.306, Comparative Medicine; transplantation with this novel Washington, DC 20015. 93.333, Clinical Research, 93.306, 93.333, Contact Person: Lawrence Ka-Yun Ng, lentiviral vector. This technology could 93.337, 93.393–93.396, 93.837–93.844, Ph.D., Scientific Review Officer, Center for 93.846–93.878, 93.892, 93.893, National provide an alternative therapy for Scientific Review, National Institutes of Institutes of Health, HHS) patients suffering from blood disorders Health, 6701 Rockledge Drive, Room 6152, associated with beta-globin gene MSC 7804, Bethesda, MD 20892, 301–357– Dated: May 15, 2015. mutations. 9318, ngkl@csr.nih.gov. Anna Snouffer, Potential Commercial Applications: Name of Committee: Endocrinology, Deputy Director, Office of Federal Advisory Gene therapy. Metabolism, Nutrition and Reproductive Committee Policy. Competitive Advantages: Sciences Integrated Review Group; Cellular [FR Doc. 2015–12242 Filed 5–19–15; 8:45 am] • Increased viral titers Aspects of Diabetes and Obesity Study BILLING CODE 4140–01–P • Increased transduction efficiency Section. • Large scale vector production Date: June 18, 2015. Development Stage: Time: 8:00 a.m. to 6:00 p.m. DEPARTMENT OF HEALTH AND • Early-stage Agenda: To review and evaluate grant • In vitro data available applications. HUMAN SERVICES • In vivo data available (animal) Place: Doubletree Hotel Bethesda Inventors: Naoya Uchida and John F. (Formerly Holiday Inn Select), 8120 National Institutes of Health Wisconsin Avenue, Bethesda, MD 20814. Tisdale (NHLBI). Contact Person: Alexander D Politis, Ph.D., Government-Owned Inventions; Intellectual Property: HHS Reference Scientific Review Officer, Center for Availability for Licensing No. E–165–2014/0—U.S. Provisional Scientific Review, National Institutes of Application No. 62/048,881 filed Health, 6701 Rockledge Drive, Room 3210, AGENCY: National Institutes of Health, September 11, 2014. MSC 7808, Bethesda, MD 20892, (301) 435– HHS. Licensing Contact: Cristina 1150, politisa@csr.nih.gov. ACTION: Notice. Thalhammer-Reyero, Ph.D.; 301–495– Name of Committee: Endocrinology, 4507; thalhamc@mail.nih.gov. Metabolism, Nutrition and Reproductive SUMMARY: The inventions listed below Collaborative Research Opportunity: Sciences Integrated Review Group; Molecular are owned by an agency of the U.S. The National Heart, Lung and Blood and Cellular Endocrinology Study Section. mstockstill on DSK4VPTVN1PROD with NOTICES Government and are available for Institute is seeking statements of Date: June 18, 2015. licensing in the U.S. in accordance with capability or interest from parties Time: 8:00 a.m. to 6:00 p.m. interested in collaborative research to 35 U.S.C. 209 and 37 CFR part 404 to Agenda: To review and evaluate grant applications. achieve expeditious commercialization further develop, evaluate or Place: Residence Inn Bethesda, 7335 of results of federally-funded research commercialize this technology. For Wisconsin Avenue, Bethesda, MD 20814. and development. Foreign patent collaboration opportunities, please Contact Person: John Bleasdale, Ph.D., applications are filed on selected contact Denise Crooks at crooksd@ Scientific Review Officer, Center for inventions to extend market coverage mail.nih.gov. VerDate Sep<11>2014 23:50 May 19, 2015 Jkt 235001 PO 00000 Frm 00086 Fmt 4703 Sfmt 4703 E:\FR\FM\20MYN1.SGM 20MYN1


Document Created: 2018-02-21 10:29:39
Document Modified: 2018-02-21 10:29:39
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesJune 15-16, 2015.
FR Citation80 FR 29013 
2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR